
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
IQVIA is proud to announce its collaboration with Friends of Cancer Research in an effort to advance acceptance and drive future uses of RWE. A recent part of this project involved a study with six research centers in the U.S. following a common protocol to assess real world endpoints among cancer patients.
To learn more, click






